A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Nasally Inhaled Dornase Alfa in the Postoperative Management of Chronic Sinusitis Due to Cystic Fibrosis
2000
Archives of Otolaryngology - Head and Neck Surgery
Objective: To determine the benefit of nasally inhaled dornase alfa in cystic fibrosis (CF) sinusitis. Design: Retrospective chart review comparing postsurgical course, radiographic studies, and pulmonary function test results in patients who were treated with nasally inhaled dornase alfa with those in patients who were not treated with dornase alfa. Patients: Twenty consecutive patients with CF who underwent functional endoscopic sinus surgery from 1993 to 1997 were included in the study.
doi:10.1001/archotol.126.5.581
pmid:10807324
fatcat:2ra2fi3vbvfevn7427zmttgad4